| | |
|---|---| [^1]
| **Symbol** | RPL34 | [^2]
| **Name** | Ribosomal Protein L34 | [^3]
| **Chromosome** | 4q32.3 |
| **NCBI Gene ID** | 6165 |
| **UniProt ID** | P49207 |
| **Gene Family** | Ribosomal protein L34e |
| **Expression** | Ubiquitous, high in bone marrow, gastrointestinal tract |
RPL34 encodes Ribosomal Protein L34, a component of the large (60S) ribosomal subunit. Ribosomal proteins are essential for protein synthesis and play roles beyond translation, including ribosome biogenesis, cell cycle regulation, and apoptosis. RPL34 has been studied primarily in the context of cancer biology, where it is frequently overexpressed, but emerging evidence suggests it may have roles in neuronal function and neurodegenerative disease.
RPL34 is a member of the ribosomal protein L34e family found in eukaryotes. The protein:
- Contains approximately 117 amino acids
- Is located in the large ribosomal subunit (60S)
- Interacts with rRNA components (28S rRNA in eukaryotes)
- Has a conserved fold typical of ribosomal proteins
¶ Expression and Regulation
RPL34 is ubiquitously expressed with highest levels in:
- Bone marrow
- Gastrointestinal tract (esophagus, stomach, small intestine)
- Lymphoid tissues
- Placenta
- Brain (moderate expression in neurons)
- Cytoplasm: Primary location for ribosomal function
- Nucleolus: Site of ribosome biogenesis
- Mitochondria: Some evidence of mitochondrial localization
RPL34 expression is regulated by:
- Cell proliferation signals (c-Myc can upregulate)
- p53 tumor suppressor
- mTOR signaling pathway
- Cellular stress responses
RPL34 participates in:
- Large subunit (60S) assembly
- rRNA binding and stabilization
- Peptidyl transferase center formation
- Ribosome quality control
As a ribosomal protein, RPL34 directly affects:
- Translation initiation rates
- Elongation efficiency
- Termination fidelity
- Ribosome recycling
Ribosomal dysfunction is a hallmark of several neurodegenerative diseases:
Alzheimer's Disease (AD
- Reduced ribosomal RNA synthesis in AD brain
- Impaired translation in neurons
- RPL34 expression altered in AD models
- Ribosomal protein aggregates in AD plaques
Parkinson's Disease (PD
- Ribosomal biogenesis defects in PD models
- Translation impairment in dopaminergic neurons
- RPL34 dysregulation in PD brain
- Connection to alpha-synuclein toxicity
Amyotrophic Lateral Sclerosis (ALS
- Ribosomal protein alterations in ALS
- Translation dysregulation in motor neurons
- Stress granule formation involving ribosomal proteins
- RPL34 involvement in ALS models
RPL34 may contribute to neurodegeneration through:
-
Translation Defects
- Impaired protein synthesis
- Reduced stress response proteins
- Synaptic protein deficits
-
Ribosomal Stress
- Ribosome biogenesis stress
- p53 activation
- Apoptosis induction
-
Protein Aggregation
- Ribosomal proteins in inclusions
- Altered liquid-liquid phase separation
-
Energy Metabolism
- Mitochondrial dysfunction
- Reduced ATP production
- Metabolic stress
RPL34 is frequently overexpressed in cancers:
- Prognostic marker in multiple tumor types
- Promotes cell proliferation
- Associated with poor prognosis
This has implications for understanding RPL34's dual role in cell survival and death.
Several approaches target ribosomal function:
- mTOR inhibitors: Affect ribosomal biogenesis
- Ribosomal RNA modifiers: Impact translation
- Small molecule inhibitors: Target specific ribosomal proteins
Potential therapeutic approaches include:
- Ribosomal stabilizers: Maintain translation
- Stress response modulators: Enhance cell survival
- Modulators of ribosomal protein expression: Restore balance
- Antisense oligonucleotides: Target specific ribosomal proteins